FDA Creates a New Advisory Committee for Genetic Metabolic Diseases – Could This Be an Opportunity to Support Rare Disease Product Development More Broadly? By Mark A. Tobolowsky & James E. Valentine & Charles G. Raver & Frank J. Sasinowski —

https://www.thefdalawblog.com/2023/12/fda-creates-a-new-advisory-committee-for-genetic-metabolic-diseases-could-this-be-an-opportunity-to-support-rare-disease-product-development-more-broadly/?utm_source=rss&utm_medium=rss&utm_campaign=fda-creates-a-new-advisory-committee-for-genetic-metabolic-diseases-could-this-be-an-opportunity-to-support-rare-disease-product-development-more-broadly